Cardiovascular Disease Screening in Pregnancy

Clin Obstet Gynecol. 2020 Dec;63(4):808-814. doi: 10.1097/GRF.0000000000000565.

Abstract

Cardiovascular disease (CVD) has surpassed the traditional causes of pregnancy-related mortality, including hemorrhage and thromboembolism in the United States. CVD accounts for ~15.5% of all pregnancy-related deaths. Pregnancy is a "natural cardiovascular stress test" for a woman. The physiological changes in the maternal hemodynamics that are geared to accommodate the growing needs of the fetal-placental unit may also lead to symptoms that are indistinguishable from those of CVD, especially in the third trimester of pregnancy. It is imperative that an obstetric provider is able to differentiate symptoms of normal pregnancy from those of a pathologic process.

MeSH terms

  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular System*
  • Female
  • Humans
  • Mass Screening
  • Placenta
  • Pregnancy
  • Pregnancy Trimester, Third